Then, to test our primary hypothesis that heparanase-mediated augmentation of insulin signaling contributes to PDAC tumor progression, we investigated the biological consequences of insulin stimulation in the presence of increased levels of heparanase in PDAC cells, starting with the mitogenic effect of insulin. The gene discussed is INS; the disease is neoplasm.